<DOC>
	<DOCNO>NCT00767507</DOCNO>
	<brief_summary>The purpose study demonstrate patient receive cangrelor infusion coronary artery bypass graft acceptable safety profile undergo surgery without excessive bleed peri-operatively .</brief_summary>
	<brief_title>Maintenance Platelet Inhibition With Cangrelor</brief_title>
	<detailed_description />
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Cangrelor</mesh_term>
	<criteria>Written inform consent 18 Years Age Non emergent coronary bypass graft surgery Received thienopyridine within 48 hour prior enrollment Confirmed suspect pregnancy Cerebrovascular accident within one yar Intracranial neoplasm History bleed diathesis Thrombocytopenia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>